EUVIMEDEUVIMED entdecken
Crossref

Synthetic Antibody Mimetics with ROS‐Gated Saccharide Release for Targeted Colitis Therapy

Yan Zhang, Song Li, Qiang Li, Ruiyuan Wang, Yue Sun, Yichun Wang, Xiaomin Yan, Xiaojian Wang, Yufeng Wang, Yadong Xue, Chao Ding, Jianfeng Gong und 2 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yan Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry For Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Colitis, Reactive Oxygen Species, Antibodies. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Analytical Chemistry for Life Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional targeted therapies for inflammatory bowel disease (IBD) often rely on unstable biological recognition elements. While molecularly imprinted polymers (MIP) offer robust synthetic alternatives, their utility is limited by an “always‐on” binding state: even weak non‐specific adsorption can significantly compromise their target‐binding capacity. We convert static MIP into reactive oxygen species (ROS)‐activated therapeutic actuators by conjugating mannose to transferrin‐imprinted MIP via a ROS‐cleavable linker. The saccharide acts dually as a therapeutic agent and a protective cloak. It sterically blocks non‐specific binding during intestinal transit. At inflammatory sites, elevated ROS levels (higher than in healthy tissue) trigger simultaneous mannose release and activation of high‐affinity targeting. This enables precise MIP anchoring to the inflamed epithelium for physical barrier formation and localized microbiome modulation. In murine colitis models, this achieved mucosal healing, mitigated inflammation, and microbiota rebalancing using a mannose equivalent dose of 27.2 mg/kg/d, benchmarking against free mannose and non‐responsive MIP controls. This work establishes a generalizable paradigm for targeted recognition and drug delivery in complex physiological environments, paving the way for intelligent, disease‐responsive nanomedicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisReactive Oxygen SpeciesAntibodiesAnimalsMiceMannosePolymersHumansTransferrinMice, Inbred C57BLMolecular Imprinting

Stichwörter der Autor:innen

IBDROS‐responsive releasemolecularly imprinted polymermucus barriertargeted saccharide delivery

Substanzen

Reactive Oxygen SpeciesMannosePolymersTransferrinAntibodies

Autor:innen und Institutionen

  • State Key Laboratory of Analytical Chemistry For Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.
  • Department of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing, China.
  • Department of Chemistry, The University of Hong Kong, Hong Kong, China.
  • Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
  • Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

ORCID-Profile: Lin Ding

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Analytical Chemistry for Life Science

Zitieren

APA

Zhang, Y., Li, S., Li, Q., Wang, R., Sun, Y., Wang, Y., Yan, X., Wang, X., Wang, Y., Xue, Y., Ding, C., Gong, J., Ding, L., & Ju, H. (2026). Synthetic Antibody Mimetics with ROS‐Gated Saccharide Release for Targeted Colitis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505869

Vancouver

Zhang Y, Li S, Li Q, Wang R, Sun Y, Wang Y, et al. Synthetic Antibody Mimetics with ROS‐Gated Saccharide Release for Targeted Colitis Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505869

BibTeX
@article{Zhang2026,
  author = {Zhang, Yan and Li, Song and Li, Qiang and Wang, Ruiyuan and Sun, Yue and Wang, Yichun and Yan, Xiaomin and Wang, Xiaojian and Wang, Yufeng and Xue, Yadong and Ding, Chao and Gong, Jianfeng and Ding, Lin and Ju, Huangxian},
  title = {Synthetic Antibody Mimetics with ROS‐Gated Saccharide Release for Targeted Colitis Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505869}
}
Kostenlos starten →